These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 28870206

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MicroRNA-34a and microRNA-21 play roles in the chemopreventive effects of 3,6-dihydroxyflavone on 1-methyl-1-nitrosourea-induced breast carcinogenesis.
    Hui C, Yujie F, Lijia Y, Long Y, Hongxia X, Yong Z, Jundong Z, Qianyong Z, Mantian M.
    Breast Cancer Res; 2012 May 22; 14(3):R80. PubMed ID: 22616882
    [Abstract] [Full Text] [Related]

  • 4. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV, Botezatu A, Plesa A, Huica I, Fudulu A, Albulescu A, Bostan M, Mihaila M, Grancea C, Manda DA, Dobrescu R, Vladoiu SV, Anton G, Badiu CV.
    Cancer Biomark; 2020 May 22; 28(2):255-268. PubMed ID: 32390600
    [Abstract] [Full Text] [Related]

  • 5. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ, Lodh A, Choi JH, van Riggelen J.
    Epigenetics Chromatin; 2019 Jul 02; 12(1):41. PubMed ID: 31266538
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
    Banerjee A, Bardhan A, Sarkar P, Datta C, Pal DK, Saha A, Ghosh A.
    Pathol Res Pract; 2024 Jan 02; 253():154970. PubMed ID: 38056136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D, Deb M, Rath SK, Kar S, Parbin S, Pradhan N, Patra SK.
    Exp Cell Res; 2016 Aug 15; 346(2):176-87. PubMed ID: 27475839
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Interaction between miR-21 and DNA methylation in different breast cancer cells].
    Zhang YY, Tian WP, Mei M.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2015 May 15; 31(3):220-4. PubMed ID: 26387181
    [Abstract] [Full Text] [Related]

  • 13. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
    Neri F, Dettori D, Incarnato D, Krepelova A, Rapelli S, Maldotti M, Parlato C, Paliogiannis P, Oliviero S.
    Oncogene; 2015 Aug 06; 34(32):4168-76. PubMed ID: 25362856
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
    Wu J, Li H, Shi M, Zhu Y, Ma Y, Zhong Y, Xiong C, Chen H, Peng C.
    J Exp Clin Cancer Res; 2019 Aug 09; 38(1):348. PubMed ID: 31399111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.